AU2719801A - Use of ngf for the manufacturing of a drug for treating allergic disorders - Google Patents

Use of ngf for the manufacturing of a drug for treating allergic disorders

Info

Publication number
AU2719801A
AU2719801A AU27198/01A AU2719801A AU2719801A AU 2719801 A AU2719801 A AU 2719801A AU 27198/01 A AU27198/01 A AU 27198/01A AU 2719801 A AU2719801 A AU 2719801A AU 2719801 A AU2719801 A AU 2719801A
Authority
AU
Australia
Prior art keywords
ngf
drug
manufacturing
allergic disorders
treating allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27198/01A
Inventor
Thomas Lundeberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medscand Medical AB
Original Assignee
Medscand Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medscand Medical AB filed Critical Medscand Medical AB
Publication of AU2719801A publication Critical patent/AU2719801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU27198/01A 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders Abandoned AU2719801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904863A SE9904863D0 (en) 1999-12-30 1999-12-30 New use
SE9904863 1999-12-30
PCT/SE2000/002698 WO2001049313A1 (en) 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders

Publications (1)

Publication Number Publication Date
AU2719801A true AU2719801A (en) 2001-07-16

Family

ID=20418378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27198/01A Abandoned AU2719801A (en) 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders

Country Status (3)

Country Link
AU (1) AU2719801A (en)
SE (1) SE9904863D0 (en)
WO (1) WO2001049313A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002366222A1 (en) * 2001-11-19 2003-06-10 Novartis Ag Use of an ascomycin for the treatment of blepharitis
EP1891966B1 (en) * 2002-12-20 2012-02-15 H. Lundbeck A/S Modulation of activity of neurotrophins; screening method
DK2120997T3 (en) 2006-12-21 2017-05-08 H Lundbeck As MODULATION OF PRO-NEUROTROPHIN ACTIVITY
EP2231179A2 (en) * 2007-12-20 2010-09-29 Cytos Biotechnology AG Ngf conjugates and uses thereof
CA2856451A1 (en) * 2012-01-05 2013-07-11 Beech Tree Labs, Inc. Method of treating pain by administration of nerve growth factor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242564A (en) * 1994-03-02 1995-09-19 Sagami Chem Res Center Bone formation accelerator
CA2286137A1 (en) * 1997-04-11 1998-10-22 Roche Diagnostics Gmbh Ngf for the prevention of demyelination in the nervous system
KR100743894B1 (en) * 1998-02-27 2007-07-30 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Vaccines, Immunotherapeutics and Methods for Using the Same

Also Published As

Publication number Publication date
SE9904863D0 (en) 1999-12-30
WO2001049313A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
AU2180400A (en) A pharmaceutical combination for the treatment of depression
AU2002356871A1 (en) Heteroaromatic carboxamide derivatives for the treatment of inflammation
AU6462500A (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
IL153425A0 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
AU6910600A (en) Methods for the treatment of mental disorders
AU1356201A (en) Treatment of hyperproliferative disorders
AU2001274526A1 (en) Remedies for allergic diseases and process for producing the same
AU5912900A (en) Quinuclidine derivatives for treatment of neurological disorders
AU2719801A (en) Use of ngf for the manufacturing of a drug for treating allergic disorders
AU7106300A (en) Treatment of skin disorders
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
AU2002218750A1 (en) Photoactivated drug therapy
AU2080201A (en) Treatment of addiction disorders
AU6076000A (en) Cyclic amine derivatives for the treatment of neurological diseases
AU2002358574A1 (en) Therapeutic benzamide derivatives
AU2002358076A1 (en) Therapeutic benzamide derivatives
AU1405001A (en) Treatment of diseases
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
HUP0202098A3 (en) Use of 2-aminotetralin derivatives for production of pharmaceutical composition for the therapy of glaucoma
AU7975500A (en) Drug for treatment of immunodeficiency states
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
AU2002250756A1 (en) A method for decreasing superoxide anion production and for the treatment of diseases associated with oxidative stress
AU5689300A (en) Thiochroman derivatives against neurological disorders
AU4453301A (en) Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
AU2716599A (en) Use of phenylthienylmethylene piperidine derivative in the manufacture of a medicament for the treatment of movement disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase